Followers | 800 |
Posts | 118388 |
Boards Moderated | 0 |
Alias Born | 11/20/2004 |
Sunday, September 28, 2014 1:36:55 PM
The information presented in this table is based on 400,000,000 shares of our common stock outstanding on June 25, 2014. Unless otherwise indicated, the address of each of the named executive officers and directors and 5% or more stockholders named below is c/o Atrinsic, Inc., 1 Grand Central Place, Suite 2319, New York, NY 10165.
Name of Beneficial Owner
Number of Shares
Beneficially Owned
Percent of
Class
Edward Gildea, Chief Executive Officer and Director 100,000,000 (1) 20.00 %
Jonathan Schechter, Director 50,000,000 (2) 11.11 %
All directors and executive officers as a group (2 persons) 150,000,000 (3) 27.27 %
5% Stockholders:
Sebastian Giordano 125,000,000 (4) 23.81 %
Hudson Bay Capital Management LP. (5)(7) 44,395,067 (7) 9.99 %
Iroquois Capital Management LLC (6)(7) 44,395,067 (7) 9.99 %
469 Holdings LLC (8) 22,693,437 5.67 %
Brilliant Digital Entertainment Altent, Inc. (9) 62,519,414 15.63 %
Google, Inc. (10) 100,047,815 25.01 %
MediaNet Digital, Inc. (11) 20,071,696 5.02 %
____________________
Recent PTIX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 08:50:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 10:18:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:02:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/02/2023 08:29:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 04:48:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:29:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM